Skip to main content
SpringerLink
Log in

Embolization for Lung Tumors

  • Living reference work entry
  • First Online:
Interventional Oncology

  • 9 Accesses

Abstract

Lung chemoembolization can safely and effectively treat large and multifocal lung tumors (including mediastinal lymph nodes), in patients with no other good treatment options. Most lung tumors are supplied by the bronchial artery, but they can also be supplied by a nonbronchial systemic artery, or the pulmonary artery. The angiograms must be carefully reviewed for tiny vessels that supply the spinal cord or esophagus. Cone beam CT or helical CT (in an integrated angiography/CT suite) must be performed to confirm that the artery supplies the tumor, and does not supply esophagus or spinal cord. The optimal intra-arterial drug and embolic for lung chemoembolization are unknown. Response rates range from 7–78%, but it is not known whether radiographic response will translate into improved survival or quality of life. We recommend that this new technique should generally be performed in the setting of a clinical trial.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

References

  1. Boas FE, Kemeny NE, Sofocleous CT, Yeh R, Thompson VR, Hsu M, et al. Phase I study of transarterial chemoembolization of lung metastases. Submitted to Radiology. 2021;301(2):474–84.

    Google Scholar 

  2. Milne EN, Zerhouni EA. Blood supply of pulmonary metastases. J Thorac Imaging. 1987;2(4):15–23.

    Article  CAS  PubMed  Google Scholar 

  3. Vogl TJ, Lehnert T, Zangos S, Eichler K, Hammerstingl R, Korkusuz H, et al. Transpulmonary chemoembolization (TPCE) as a treatment for unresectable lung metastases. Eur Radiol. 2008;18(11):2449–55.

    Article  PubMed  Google Scholar 

  4. Boas FE, Brown KT, Ziv E, Yarmohammadi H, Sofocleous CT, Erinjeri JP, et al. Aspirin is associated with improved liver function after embolization of hepatocellular carcinoma. AJR Am J Roentgenol. 2019;213(3):1–7.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Zener R, Yoon H, Ziv E, Covey A, Brown KT, Sofocleous CT, et al. Outcomes after transarterial embolization of neuroendocrine tumor liver metastases using spherical particles of different sizes. Cardiovasc Intervent Radiol. 2019;42(4):569–76.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Maluccio MA, Covey AM, Schubert J, Brody LA, Sofocleous CT, Getrajdman GI, et al. Treatment of metastatic sarcoma to the liver with bland embolization. Cancer. 2006;107(7):1617–23.

    Article  PubMed  Google Scholar 

  7. Shimohira M, Sato Y, Yasumoto T, Kodama Y, Masada T, Inaba Y, et al. Arterial embolization using microspheres for hypervascular liver metastases refractory to standard treatments: a multicenter prospective clinical trial. Cardiovasc Intervent Radiol. 2021;44(3):392–400.

    Article  PubMed  Google Scholar 

  8. Seki A, Hori S, Sueyoshi S, Hori A, Kono M, Murata S, et al. Transcatheter arterial embolization with spherical embolic agent for pulmonary metastases from renal cell carcinoma. Cardiovasc Intervent Radiol. 2013;36(6):1527–35.

    Article  PubMed  Google Scholar 

  9. Jin B, Wang D, Lewandowski RJ, Riaz A, Ryu RK, Sato KT, et al. Chemoembolization endpoints: effect on survival among patients with hepatocellular carcinoma. AJR Am J Roentgenol. 2011;196(4):919–28.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Maxwell AWP, Mendoza HG, Sellitti MJ, Camacho JC, Deipolyi AR, Ziv E, et al. Effects of particle density on outcomes after lobar radioembolization. Submitted to CVIR. 2022;45:958–69.

    Google Scholar 

  11. Zheng XH, Guan YS, Zhou XP, Huang J, Sun L, Li X, et al. Detection of hypervascular hepatocellular carcinoma: comparison of multi-detector CT with digital subtraction angiography and Lipiodol CT. World J Gastroenterol. 2005;11(2):200–3.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Gruber-Rouh T, Naguib NN, Eichler K, Ackermann H, Zangos S, Trojan J, et al. Transarterial chemoembolization of unresectable systemic chemotherapy-refractory liver metastases from colorectal cancer: long-term results over a 10-year period. Int J Cancer. 2014;134(5):1225–31.

    Article  CAS  PubMed  Google Scholar 

  13. Yarmohammadi H, Gonzalez-Aguirre AJ, Schook L, Ziv E, Erinjeri JP, Brown KT, et al. Treatment of pancreatic cancer by intra-arterial injection of an emulsion of lipiodol and bumetanide (an anti-glycolytic drug) in a porcine model: initial results. J Vasc Interv Radiol. 2017;28(2):S8–9.

    Article  Google Scholar 

  14. Yoshida H, Onda M, Tajiri T, Uchida E, Arima Y, Mamada Y, et al. Experience with intraarterial infusion of styrene maleic acid neocarzinostatin (SMANCS)-lipiodol in pancreatic cancer. Hepato-Gastroenterology. 1999;46(28):2612–5.

    CAS  PubMed  Google Scholar 

  15. Tsuchiya K, Uchida T, Kobayashi M, Maeda H, Konno T, Yamanaka H. Tumor-targeted chemotherapy with SMANCS in lipiodol for renal cell carcinoma: longer survival with larger size tumors. Urology. 2000;55(4):495–500.

    Article  CAS  PubMed  Google Scholar 

  16. de Baere T, Zhang X, Aubert B, Harry G, Lagrange C, Ropers J, et al. Quantification of tumor uptake of iodized oils and emulsions of iodized oils: experimental study. Radiology. 1996;201(3):731–5.

    Article  PubMed  Google Scholar 

  17. Miszczuk MA, Chapiro J, Geschwind JH, Thakur V, Nezami N, Laage-Gaupp F, et al. Lipiodol as an imaging biomarker of tumor response after conventional transarterial chemoembolization: prospective clinical validation in patients with primary and secondary liver cancer. Transl Oncol. 2020;13(3):100742.

    Article  PubMed  PubMed Central  Google Scholar 

  18. Nakanishi M, Demura Y, Umeda Y, Mizuno S, Ameshima S, Chiba Y, et al. Multi-arterial infusion chemotherapy for non-small cell lung carcinoma–significance of detecting feeding arteries and tumor staining. Lung Cancer. 2008;61(2):227–34.

    Article  PubMed  Google Scholar 

  19. Zeng Y, Yin M, Zhao Y, Liu Y, Li X, Qi Y, et al. Combination of bronchial arterial infusion chemotherapy plus drug-eluting embolic transarterial chemoembolization for treatment of advanced lung cancer-a retrospective analysis of 23 patients. J Vasc Interv Radiol. 2020;31(10):1645–53.

    Article  PubMed  Google Scholar 

  20. Yuan Z, Li WT, Ye XD, Dong S, Peng WJ. Intra-arterial infusion chemotherapy for advanced non-small-cell lung cancer: preliminary experience on the safety, efficacy, and clinical outcomes. J Vasc Interv Radiol. 2013;24(10):1521–8.e4.

    Article  PubMed  Google Scholar 

  21. Hori A, Ohira R, Nakamura T, Kimura Y, Ueda S, Torii M, et al. Transarterial chemoembolization for pulmonary or mediastinal metastases from hepatocellular carcinoma. Br J Radiol. 2020;93(1110):20190407.

    Article  PubMed  Google Scholar 

  22. Duan F, Wang MQ, Liu FY, Wang ZJ, Song P, Wang Y. Sorafenib in combination with transarterial chemoembolization and bronchial arterial chemoinfusion in the treatment of hepatocellular carcinoma with pulmonary metastasis. Asia Pac J Clin Oncol. 2012;8(2):156–63.

    Article  PubMed  Google Scholar 

  23. Kennoki N, Hori S, Yuki T, Hori A. Transcatheter arterial chemoembolization with spherical embolic agent in patients with pulmonary or mediastinal metastases from breast cancer. J Vasc Interv Radiol. 2017;28(10):1386–94.

    Article  PubMed  Google Scholar 

  24. Vogl TJ, Mekkawy AIA, Thabet DB, El-Sharkaway M, Kamel HM, Albrecht MH, et al. Transvenous pulmonary chemoembolization (TPCE) for palliative or neoadjuvant treatment of lung metastases. Eur Radiol. 2019;29(4):1939–49.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. City of Hope, Duarte, CA, USA

    F. Edward Boas

Authors
  1. F. Edward Boas
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to F. Edward Boas .

Editor information

Editors and Affiliations

  1. Department of Surgery and Radiology Memorial Sloan-Kettering Cancer Center, New York, NY, USA

    Yuman Fong

  2. Diagnostic Radiology, Room H-118, Memorial Sloan Kettering Cancer Center, New York, NY, USA

    Anne Covey

  3. Department of Radiology, Beth Israel Deaconess Medical Center, Boston, MA, USA

    Muneeb Ahmed

  4. City Of Hope National Medical Center, Duarte, CA, USA

    Jonathan Kessler

  5. Department of Surgery, Carolinas Medical Center, Charlotte, NC, USA

    David A. Iannitti

  6. Department of Radiology, Cape Cod Hospital, Hyannis, MA, USA

    Damian E. Dupuy

Section Editor information

  1. Cape Cod Hospital Radiology, Cape Cod Hospital, Hyannis, MA, USA

    Damian E. Dupuy MD

Rights and permissions

Reprints and permissions

Copyright information

© 2024 Springer Nature Switzerland AG

About this entry

Check for updates. Verify currency and authenticity via CrossMark

Cite this entry

Boas, F.E. (2024). Embolization for Lung Tumors. In: Fong, Y., Covey, A., Ahmed, M., Kessler, J., Iannitti, D.A., Dupuy, D.E. (eds) Interventional Oncology. Springer, Cham. https://doi.org/10.1007/978-3-030-51192-0_93-1

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-51192-0_93-1

  • Received:

  • Accepted:

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-51192-0

  • Online ISBN: 978-3-030-51192-0

  • eBook Packages: Springer Reference MedicineReference Module Medicine

Publish with us

Policies and ethics

Search

Navigation